Image de couverture de livre

The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Scott W. Kirkland, Lloyd Visser, Jillian Meyer, Daniela R. Junqueira, Sandra Campbell, Cristina Villa‐Roel, Benjamin W. Friedman, Nana Owusu Essel, Brian H. Rowe
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Headache: The Journal of Head and Face Pain
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2025)

The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2024)

Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies
par: Jennifer Robblee, et autres
Publié: (2024)

Youth with high‐frequency headaches due to migraine are more vulnerable to non‐cephalic pain complaints
par: Brooke L. Reidy, et autres
Publié: (2025)

The role of stress in the comorbidity of migraine and other chronic primary pain
par: Shi‐Jie Zhao, et autres
Publié: (2025)

Microneedles for the treatment of migraine and orofacial pain: A narrative review
par: Baicheng Cao, et autres
Publié: (2026)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
par: Alexander Yoo, et autres
Publié: (2025)

Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine
par: Haley C. Cropper, et autres
Publié: (2024)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
par: M. Ismail K. Yousaf, et autres
Publié: (2025)

Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study
par: Alexis Espanioli, et autres
Publié: (2025)

The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model
par: Philip Victor Reducha, et autres
Publié: (2024)

Implications of high homocysteine levels in migraine pain: An experimental study of the excitability of peripheral meningeal afferents in rats with hyperhomocysteinemia
par: Elizaveta Ermakova, et autres
Publié: (2024)

Driving evidence to practice for management of migraine in the emergency department: A systematic approach to guideline implementation
par: Jennifer Robblee, et autres
Publié: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
par: Richard B. Lipton, et autres
Publié: (2026)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
par: Geneviève Tourigny‐Ruel, et autres
Publié: (2026)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
par: Graham A. McLeod, et autres
Publié: (2025)

A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
par: Meesha Trivedi, et autres
Publié: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
par: Rikki Mangrum, et autres
Publié: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
par: Yunus Emre Meydanal, et autres
Publié: (2025)

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial
par: Serena Laura Orr, et autres
Publié: (2024)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
par: Nan Cheng, et autres
Publié: (2025)

Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data
par: Marina Vives‐Mestres, et autres
Publié: (2024)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
par: Jonathan R. Treadwell, et autres
Publié: (2025)

Retrofitted adult interventions aren't good enough: Why children and adolescents deserve tailored evidence‐based care for migraine in the emergency department
par: Serena L. Orr
Publié: (2026)

Evaluating associations of migraine‐related vertigo
par: Nazia Karsan, et autres
Publié: (2025)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
par: Lawrence C. Newman, et autres
Publié: (2025)

Afterimage duration differs for migraine with or without aura
par: Florian Rimmele, et autres
Publié: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
par: Rebecca Erwin Wells, et autres
Publié: (2024)

Useful considerations for treating migraine in patients with autism
par: Sinifunanya E. Nwaobi
Publié: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
par: Gabriel Camargo de Oliveira, et autres
Publié: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
par: Shuu‐Jiun Wang, et autres
Publié: (2024)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
par: Inga Zalia Tummoszeit, et autres
Publié: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
par: Chia‐Chun Chiang, et autres
Publié: (2024)

The 2024 Scottsdale Headache Symposium: A banner year
par: Deborah I. Friedman, et autres
Publié: (2024)

The 2025 Scottsdale Headache Symposium: New beginnings
par: Deborah I. Friedman, et autres
Publié: (2025)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
par: Richard B. Lipton, et autres
Publié: (2025)

Perceptions of health, cognition, and pain among middle‐aged and older adults with migraine: A population‐based cross‐sectional study examining findings from the Canadian Longitudinal Study on Aging
par: Makenna K. N. Jensen, et autres
Publié: (2025)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
par: Samantha C. Shao, et autres
Publié: (2024)

Counting the cost: How migraine shapes lives and economies
par: Risako Shirane, et autres
Publié: (2025)

Cardiovascular risk and triptan usage among patients with migraine
par: Ido Peles, et autres
Publié: (2025)